| Nov 5 |
Should Investors Buy Weakness in These High-Growth Stocks?
|
| Nov 5 |
Lilly announces details of presentations at the 2024 American Society of Hematology (ASH) Annual Meeting
|
| Nov 5 |
Hims & Hers Stock Jumps. A Generic Version of Novo Nordisk Diabetes Drug Is Close.
|
| Nov 5 |
Hims & Hers Health jumps on earnings. CFO talks GLP-1 influences.
|
| Nov 4 |
Is Eli Lilly and Company (LLY) the Best Pharma Stock to Buy Right Now?
|
| Nov 4 |
What Wall Street Analysts Think of Novo Nordisk's Stock Ahead of Earnings
|
| Nov 4 |
Viking Therapeutics stock falling amid results for new GLP-1 pill
|
| Nov 4 |
How does Viking's weight loss med compare to ones from Novo, Eli Lilly?
|
| Nov 4 |
Eczema Drug Developer Nektar Gains Analyst Confidence With 400% Upside Potential
|
| Nov 4 |
Eczema Drug Developer Nektar Gains Analyst Confidence With 400% Upside Potential
|
